A new report published on Wednesday reveals a significant decline in cancer-related deaths across the US. According to the American Cancer Society, it is the greatest ever downturn between 2016 and 2017, since 1992. Reportedly, the overall cancer death rate is declining around 1.5% every year for the past more than two decades. Federal officials had formerly reported a bit lower fall in the cancer death rate for the same time. But the Cancer Society estimates the death rate in a different way, and it is record-breaking. Researchers say the credit of such a massive decline goes to advances in the medication therapies of lung cancer.
The study, published in CA: A Cancer Journal for Clinicians, the US has seen a massive 2.2% decline to some extent by a sharp downfall in deaths related to lung cancer. Lung cancer is one of the leading causes of death from cancer in the US. It accounts for around 27% of all cancer-related deaths. But the number is more than a collective number of demises that occur due to other cancers. Lung cancer is the predominant reason for death among men having age 40 and more and women aged 60 and above. The report also reveals a considerable fall in death from melanoma, a fatal type of skin cancer. The progress arrives after the FDA approved the latest medications for cancer spread across other portions of the body.
Rebecca Siegel, leading author of the study, said the results are crucial and reflect upgrades in the medication of lung cancer across the range. It includes enhancements in surgical techniques, radiotherapy, etc. She added they were very inspired to see that the death rate is not only declining, but it is the highest single-year fall since 2017. Dr. Jyoti Patel, a lung cancer expert from Northwestern University, said therapies have offered years of life to patients with end-stage cancers. Before this, such patients used to survive for months only. Well, it’s the magic of the latest medications and innovations. Dr. Jyoti added new immunotherapy drugs could boost the death rate drop.